文献速递认知障碍与痴呆

认知正常人群的ATN谱与纵向认知结局

ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes.
PubMed 文献 · Neurology · 2019-03-06

该研究汇总4项队列研究共814名基线认知正常者(平均基线年龄59.6岁),依据基线脑脊液β-淀粉样蛋白1-42、磷酸化tau181和总tau水平分为8个ATN组,用生长曲线模型比较平均7年随访的认知轨迹。结果显示仅A+T+N+组认知下降持续大于A-T-N-组,支持脑内淀粉样蛋白升高与神经原纤维缠结同时存在才导致加速神经变性和认知下降的假说。

要点

  • 认知正常者中仅A+T+N+谱与认知下降加速相关
  • 按2011 NIA-AA/suspected non-AD pathophysiology分期,仅stage 2认知下降大于stage 0
  • 淀粉样蛋白与tau同时异常可能是认知下降的关键条件

核心结论

  • 结果支持脑内淀粉样蛋白升高与神经原纤维缠结同时存在才观察到加速神经变性,进而导致认知下降的假说。

研究设计与样本

  • 汇总4项队列研究,纳入814名基线认知正常参与者(平均基线年龄59.6岁),用基线脑脊液β-淀粉样蛋白1-42、磷酸化tau181和总tau水平分为8个ATN组。
  • 用生长曲线模型比较各组认知轨迹,平均随访时间7年;认知用先前验证的全局因子评分和简易精神状态检查测量。

主要发现

  • 使用不同模型设定和生物标志物异常切点时,仅A+T+N+组认知下降持续大于A-T-N-组。
  • 按2011 NIA-AA/suspected non-Alzheimer disease pathophysiology schema,仅淀粉样蛋白和磷酸化tau181或总tau均异常(stage 2)者认知下降大于生物标志物正常(stage 0)者。

临床怎么用

  • 对认知正常者解读ATN谱时,应关注淀粉样蛋白与tau同时异常(A+T+N+或stage 2)提示认知下降风险较高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the long-term cognitive trajectories of individuals with normal cognition at baseline and distinct amyloid/tau/neurodegeneration (ATN) profiles. METHODS: Pooling data across 4 cohort studies, 814 cognitively normal participants (mean baseline age = 59.6 years) were classified into 8 ATN groups using baseline CSF levels of β-amyloid 1-42 as a measure of amyloid (A), phosphorylated tau 181 as a measure of tau (T), and total tau as a measure of neurodegeneration (N). Cognitive performance was measured using a previously validated global factor score and with the Mini-Mental State Examination. We compared the cognitive trajectories across groups using growth curve models (mean follow-up time = 7 years). RESULTS: Using different model formulations and cut points for determining biomarker abnormality, only the group with abnormal levels of amyloid, tau, and neurodegeneration (A+T+N+) showed consistently greater cognitive decline than the group with normal levels of all biomarkers (A-T-N-). Replicating prior findings using the 2011 National Institute on Aging-Alzheimer's Association/suspected non-Alzheimer disease pathophysiology schema, only individuals with abnormal levels of both amyloid and phosphorylated tau 181 or total tau (stage 2) showed greater cognitive decline than those with normal biomarker levels (stage 0). CONCLUSION: The results are consistent with the hypothesis that both elevated brain amyloid and neurofibrillary tangles are necessary to observe accelerated neurodegeneration, which in turn leads to cognitive decline.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Soldan A, Pettigrew C, Fagan AM, et al. ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes. Neurology. 2019. PMID: 30842300. doi:10.1212/WNL.0000000000007248

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。